Skip to main content
Log in

Intravenous Albumin Shortens the Duration of Hospitalization for Patients with Hypoalbuminemia and Bleeding Peptic Ulcers: A Pilot Study

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Patients with hypoalbuminemia have an increased risk of ulcer rebleeding and longer length of hospitalization.

Aims

This study aimed to test whether intravenous albumin can decrease the incidence of rebleeding or shorten the duration of hospitalization in patients with bleeding peptic ulcers and hypoalbuminemia.

Methods

Sixty-two patients with bleeding peptic ulcers and Rockall scores ≥6 were prospectively enrolled after having received endoscopic therapy. The enrolled patients were divided into a normal albumin group (serum albumin ≥3 g/dL, n = 39) or an intervention group (<3 g/dL, n = 23) to receive a 3-day course of omeprazole infusion and 25-day oral esomeprazole. Patients (n = 29) with bleeding ulcers and hypoalbuminemia who received the same dose of intravenous and oral omeprazole but did not receive albumin therapy were enrolled from a previous study as the control group. In the intervention group, patients received albumin infusion (10 g q8h) for 1 day (serum albumin levels 2.5–2.9 g/dL) and 2 days (<2.5 g/dL), respectively.

Results

The 28-day cumulative rebleeding rates were similar between the intervention group and the control group (39.1 vs. 42.3 %, p = 0.99). The intervention group had a shorter duration of hospitalization (9 vs. 15 days, p = 0.02) than cohort controls. The risk of rebleeding developed after discharge were similar (normal albumin group vs. intervention group vs. control group, 1/5 [20 %] vs. 2/9 [22.2 %] vs. 1/11 [9.1 %], p = 0.7).

Conclusions

Albumin administration shortens the duration of hospitalization for patients with peptic ulcer bleeding and hypoalbuminemia, but does not decrease the incidence of rebleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

SRH:

Stigmata of recent hemorrhage

IQR:

Interquartile range

GU:

Gastric ulcer

DU:

Duodenal ulcer

EU:

Esophageal ulcer

H. pylori :

Helicobacter pylori

NSAID:

Non-steroidal anti-inflammatory drugs

ASA:

American Society of Anesthesiologists

PT:

Pro-thrombin time

APTT:

Activated partial thromboplastin time

ITT:

Intention-to-treat

PP:

Per-protocol

U:

Unit

Hb:

Hemoglobin

References

  1. Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol. 1995;90:568–573.

    PubMed  CAS  Google Scholar 

  2. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol. 1985;90:206–210.

    Google Scholar 

  3. Silvertstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J, 277 members of the ASGE. The National ASGE Survey on upper gastrointestinal bleeding. I. Study design and baseline data. Gastrointest Endosc. 1981;27:73–79.

    Article  Google Scholar 

  4. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316–321.

    Article  PubMed  CAS  Google Scholar 

  5. Katschinski B, Logan R, Davies J, Faulkner G, Pearson J, Langman M. Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci. 1994;39:6–12.

    Article  Google Scholar 

  6. Johnston JH. Endoscopic risk factors for bleeding peptic ulcer. Gastrointest Endosc. 1990;36:S16–S20.

    PubMed  CAS  Google Scholar 

  7. Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS. Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastroenterology. 2003;50:2270–2273.

    PubMed  Google Scholar 

  8. Forrest JA, Finlayson ND, Sherman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2:394–397.

    Article  PubMed  CAS  Google Scholar 

  9. Lim CH, Vani D, Shah SG, Everett SM, Rembacken BJ. The outcome of suspected upper gastrointestinal bleeding with 24-hour access to upper gastrointestinal endoscopy: a prospective cohort study. Endoscopy. 2006;38:581–585.

    Article  PubMed  CAS  Google Scholar 

  10. Terdiman JP, Ostroff JW. Gastrointestinal bleeding in the hospitalized patient: a case-control study to assess risk factors, causes, and outcome. Am J Med. 1998;104:349–354.

    Article  PubMed  CAS  Google Scholar 

  11. Cheng HC, Kao AW, Chuang CH, Sheu BS. The efficacy of high and low dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Dig Dis Sci. 2005;50:1194–1201.

    Article  PubMed  CAS  Google Scholar 

  12. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343:310–316.

    Article  PubMed  CAS  Google Scholar 

  13. Schaffalitzky de Muckadell OB, Havelund T, Harling H, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol. 1997;32:320–327.

    Article  PubMed  CAS  Google Scholar 

  14. Sheu BS, Chi CH, Huang CC, Kao AW, Wang YL, Yang HB. Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding. Aliment Pharmacol Ther. 2002;16:137–143.

    Article  PubMed  CAS  Google Scholar 

  15. Freston JW. Overview of medical therapy of peptic ulcer disease. Gastroenterol Clin N Am. 1990;9:121–140.

    Google Scholar 

  16. Kinney JM, Weissmann C. Forms of malnutrition in stressed and unstressed patients. Clin Chest Med. 1986;7:19–28.

    PubMed  CAS  Google Scholar 

  17. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319–334.

    PubMed  Google Scholar 

  18. Rady MY, Ryan T, Starr NJ. Clinical characteristics of preoperative hypoalbuminemia predict outcome of cardiovascular surgery. J Parenter Enteral Nutr. 1997;21:81–90.

    Article  CAS  Google Scholar 

  19. Kung SP, Tang GJ, Wu CW, Lui W. Serum albumin concentration as a prognostic indicator for acute surgical patients. Chin Med J (Taipei). 1999;62:61–67.

    CAS  Google Scholar 

  20. Hamilton JE, Harbrecht PJ, Robbins RE, Noland JL. The behavior and management of major acute bleeding from peptic ulcers. Surg Gynecol Obstet. 1965;121:545–550.

    PubMed  CAS  Google Scholar 

  21. Cheng HC, Chang WL, Yeh YC, Chen WY, Tsai YC, Sheu BS. Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities. Gastrointest Endosc. 2009;70:433–439.

    Article  PubMed  Google Scholar 

  22. Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Johannes RS. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74:1215–1224.

    Article  PubMed  Google Scholar 

  23. Hyett BH, Abougergi MS, Charpentier JP, et al. The AIMS65 score compared with the Glasgow-Blatchford score in predicting outcomes in upper GI bleeding. Gastrointest Endosc. 2013;77:551–557.

    Article  PubMed  Google Scholar 

  24. Uhing MR. The albumin controversy. Clin Perinatol. 2004;31:475–488.

    Article  PubMed  Google Scholar 

  25. Vincent JL, Navickis RJ, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med. 2004;32:2029–2038.

    Article  PubMed  CAS  Google Scholar 

  26. Regtien JG, Stienstra Y, Ligtenberg JJ, van der Werf TS, Tulleken JE, Zijlstra JG. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med. 2005;33:915.

    Article  PubMed  CAS  Google Scholar 

  27. Martin GS. A new twist on albumin therapy in the intensive care unit, again. Crit Care Med. 2006;34:2677–2679.

    Article  PubMed  Google Scholar 

  28. American Society of Anesthesiologists. New classification of physical status. Anesthesiology. 1963;24:111.

    Google Scholar 

  29. Yang CC, Shin JS, Lin XZ, Hsu PI, Chen KW, Lin CY. The natural history (fading time) of stigmata of recent hemorrhage in peptic ulcer disease. Gastrointest Endosc. 1994;40:562–566.

    Article  PubMed  CAS  Google Scholar 

  30. Matsui S, Kamisako T, Kudo M, Inoue R. Endoscopic band ligation for control of non-variceal non-ulcer gastrointestinal hemorrhage: comparison with bipolar electrocoagulation. Gastrointest Endosc. 2002;55:214–218.

    Article  PubMed  Google Scholar 

  31. Wang CH, Ma MH, Chou HC, et al. High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2010;170:751–758.

    Article  PubMed  CAS  Google Scholar 

  32. Sheu BS, Lin CY, Lin XZ, Shiesh SC, Yang HB, Chen CY. Long-term outcome of triple therapy in Helicobacter pylori-related non-ulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol. 1996;91:441–447.

    PubMed  CAS  Google Scholar 

  33. Sung JJ, Tsoi KK, Ma TK, Yung MY, Lau JY, Chiu PW. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol. 2010;105:84–89.

    Article  PubMed  Google Scholar 

  34. Sung JJ, Tsoi KK, Lai LH, Wu JC, Lau JY. Endoscopic clipping versus injection and thermo-coagulation in the treatment of bleeding non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut. 2007;56:1364–1372.

    Article  PubMed  Google Scholar 

  35. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper gastrointestinal haemorrhage. Lancet. 2000;356:1318–1321.

    Article  PubMed  CAS  Google Scholar 

  36. Zaragoza AM, Tenías JM, Llorente MJ, Alborch A. Prognostic factors in gastrointestinal bleeding due to peptic ulcer: construction of a predictive model. J Clin Gastroenterol. 2008;42:786–790.

    Article  PubMed  Google Scholar 

  37. Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525–531.

    Article  PubMed  Google Scholar 

  38. Peters T Jr. Serum albumin. In: Putnam FW (ed) The Plasma Proteins, 2nd edn. New York, NY: Academic Press, 1975:131–181.

    Google Scholar 

  39. Regardh CG, Gabrielsson M, Hoffman KJ, Lofberg I, Skanberg I. Pharmacokinetics and metabolism of omeprazole in animals and man-an overview. Scand J Gastroenterol. 1985;108:79–94.

    Article  CAS  Google Scholar 

  40. Emerson TE Jr. Unique features of albumin: a brief review. Crit Care Med. 1989;17:690–694.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded in part by research grants from the National Science Council of Taiwan (NSC 97-2314-B-006-038-MY3) and the National Cheng Kung University Hospital in Tainan, Taiwan (NCKUH-9904006).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bor-Shyang Sheu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, HC., Chang, WL., Chen, WY. et al. Intravenous Albumin Shortens the Duration of Hospitalization for Patients with Hypoalbuminemia and Bleeding Peptic Ulcers: A Pilot Study. Dig Dis Sci 58, 3232–3241 (2013). https://doi.org/10.1007/s10620-013-2821-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2821-8

Keywords

Navigation